Hugh Alexander Ilyine
Fondateur chez Profactor Pharma Ltd.
Profil
Hugh Alexander Ilyine is the founder of two companies.
He founded Profactor Pharma Ltd.
in 2009 and Destina Genomics Ltd.
in 2011, where he holds the title of Director and Chief Executive Officer & Executive Director, respectively.
Mr. Ilyine's former jobs include Chief Operating Officer positions at Sierra Leone Diamond Co. Ltd.
and Stem Cell Sciences Plc.
Postes actifs de Hugh Alexander Ilyine
| Sociétés | Poste | Début |
|---|---|---|
Profactor Pharma Ltd.
 Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Fondateur | 01/01/2009 |
Destina Genomics Ltd.
 Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Fondateur | 01/01/2011 |
Anciens postes connus de Hugh Alexander Ilyine
| Sociétés | Poste | Fin |
|---|---|---|
| Stem Cell Sciences Plc | Directeur des opérations | 07/04/2009 |
| Sierra Leone Diamond Co. Ltd. | Directeur des opérations | 17/08/2007 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
| Sierra Leone Diamond Co. Ltd. | Non-Energy Minerals |
| Stem Cell Sciences Plc | Commercial Services |
Profactor Pharma Ltd.
Profactor Pharma Ltd. Pharmaceuticals: MajorHealth Technology ProFactor Pharma Ltd. develops and supplies recombinant blood factors for the treatment of haemophilia. The firm commercialise and supply recombinant blood factors for the treatment of haemophilia to a undersupplied world market, starting with recombinant human Factor VIII (rhFVIII). The company was founded by Richard John Cruse, Ian Garner, Bruce Vernon, Hugh Ilyine and John H. McVey in 2009 and is headquartered in Midlothian, the United Kingdom. | Health Technology |
Destina Genomics Ltd.
Destina Genomics Ltd. BiotechnologyHealth Technology Destina Genomics Ltd. is engaged in development of molecular diagnostic products. Its products include pipeline assay kits and liverace. The company was founded by Hugh Llyine, Juan J. Diaz-Mochon and Mark Bradley in 2011 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
